Outcomes of Multiple Runs of Extracorporeal Membrane Oxygenation: An analysis of the Extracorporeal Life Support Registry

体外膜肺氧合 生命维持 医学 体外 回顾性队列研究 队列 呼吸衰竭 死亡率 存活率 急诊医学 外科 重症监护医学 内科学
作者
David S. Cooper,Ravi R. Thiagarajan,Brandon Michael Henry,Jonathan W. Byrnes,Andrew Misfeldt,Jason S. Frischer,Eileen King,Zhiqian Gao,Peter Rycus,Bradley S. Marino
出处
期刊:Journal of Intensive Care Medicine [SAGE Publishing]
卷期号:37 (2): 195-201 被引量:7
标识
DOI:10.1177/0885066620981903
摘要

When patients deteriorate after decannulation from extracorporeal membrane oxygenation (ECMO), a second run of extracorporeal support may be considered. However, repeat cannulation can be difficult and poor outcomes associated with multiple ECMO runs are a concern. The aim of this study was to evaluate outcomes and identify factors associated with survival and mortality in cases of multiple runs of extracorporeal membrane oxygenation.Retrospective cohort analysis of the Extracorporeal Life Support Organization Registry.The Extracorporeal Life Support Organization's registry was queried for neonates, children, and adults receiving 2 or more runs of ECMO during the same hospitalization, for any indication, from 1998 to 2015.1,818 patients from the Extracorporeal Life Support Organization Registry.Of the 1,818 patients, 1,648 underwent 2 runs and 170 underwent 3 or more runs of ECMO. The survival to discharge rate was 36.7% for 2 runs and 29.4% for 3 or more runs. No significant differences in survival were detected in analysis by decade of ECMO run (p = 0.21). Pediatric patients had less mortality than adults (OR: 0.45, 95%CI: 0.24-0.82). Cardiac support on the first run portrayed worse mortality than pulmonary support regardless of final run indication (OR:1.38, 95%CI: 1.09-1.75). Across all age groups, patients receiving pulmonary support on the last run tended to have higher survival rates regardless of support type on the first run. The only first run complication independently predictive of mortality on the final run was renal complications (OR: 1.60, 95%CI: 1.28-1.99).Though the use of multiple runs of ECMO is growing, outcomes remain poor for most cohorts. Survival decreases with each additional run. Patients requiring additional runs for a pulmonary indication should be considered prime candidates. Renal complications on the first run significantly increases the risk of mortality on subsequent runs, and as such, careful consideration should be applied in these cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Zpiao发布了新的文献求助20
6秒前
pluto应助科研小白采纳,获得20
7秒前
11秒前
夏xia完成签到,获得积分10
13秒前
13秒前
14秒前
木染发布了新的文献求助10
14秒前
yang完成签到,获得积分10
15秒前
猪猪女孩发布了新的文献求助10
18秒前
幽默的月光完成签到,获得积分10
19秒前
汪爷爷完成签到,获得积分10
20秒前
20秒前
恐龙妹妹完成签到 ,获得积分10
23秒前
Django关注了科研通微信公众号
23秒前
AlexanderChen发布了新的文献求助10
24秒前
fangzhang发布了新的文献求助10
25秒前
莫之白完成签到,获得积分10
26秒前
曾经的半山完成签到 ,获得积分10
27秒前
33完成签到,获得积分10
28秒前
Akim应助猪猪女孩采纳,获得10
28秒前
29秒前
32秒前
华仔应助二东采纳,获得10
34秒前
zzj-zjut发布了新的文献求助10
35秒前
z11发布了新的文献求助10
35秒前
所所应助Jimmy采纳,获得10
36秒前
一帆风顺完成签到,获得积分10
37秒前
kid1412完成签到 ,获得积分10
37秒前
40秒前
40秒前
可爱的函函应助木染采纳,获得10
45秒前
科研通AI5应助zzj-zjut采纳,获得10
45秒前
46秒前
虎虎虎发布了新的文献求助10
46秒前
二东发布了新的文献求助10
46秒前
47秒前
48秒前
49秒前
科研通AI5应助Zpiao采纳,获得10
49秒前
Django发布了新的文献求助20
50秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
China—Art—Modernity: A Critical Introduction to Chinese Visual Expression from the Beginning of the Twentieth Century to the Present Day 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3776990
求助须知:如何正确求助?哪些是违规求助? 3322387
关于积分的说明 10210034
捐赠科研通 3037721
什么是DOI,文献DOI怎么找? 1666843
邀请新用户注册赠送积分活动 797700
科研通“疑难数据库(出版商)”最低求助积分说明 758012